FDA approves guanfacine ER tablets to treat ADHD in children, teens - - Drug Topics
Links shared publicly online about this topic.
- 468total visits
FDA approves guanfacine ER tablets to treat ADHD in children, teens - - Drug Topics
drugtopics.modernmedicine.com —
FDA approved the use of once-daily guanfacine (Intuniv, Shire) extended-release tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder in children and adolescents aged 6 to 17 years as part of a total treatment program.
View full resource at drugtopics.modernmedicine.com
Tags: ADHD, ADHD Medication, Children's Health, Teen Health, FDA, Intuniv, Pediatric ADHD
Most Recently Shared on March 2, 2011 at 7:52 pm By:
FDA approves guanfacine ER tablets to treat ADHD in children, teens: FDA approved the use of once-daily gu... http://bit.ly/hRwbtM #adhd
Advertisement
